Evelyne Yehudit Bischof at ARDD2025: Metabolic Changes in the Large Cohorts and Fudan Longevity...

Value of the Information & Strength of the Argument

The presentation provides valuable insights into ongoing large-scale metabolic aging research in China, including the establishment of a unique longevity center and the development of a high-throughput metabolomics platform. The argumentation is based on preliminary data and ongoing studies, with some results unpublished. The speaker effectively communicates the potential of these approaches to improve risk stratification and personalized medicine, though the lack of detailed methodology and peer-reviewed results limits the strength of the claims.

Scientific Rigor, Source Quality, Title Accuracy

The presentation is scientifically rigorous, referencing specific cohorts, technologies, and collaborations. However, many results are unpublished or in submission, and no specific sources are cited in the talk. The title accurately reflects the content, focusing on metabolic changes and the Fudan Longevity Institute. The speaker is a credible researcher, and the content aligns with current trends in aging research.

The title accurately reflects the content, focusing on metabolic changes in large cohorts and the Fudan Longevity Institute.

7/10

Presentation by a recognized researcher at a scientific conference, describing ongoing research and collaborations. Claims are plausible but not all are peer-reviewed; some data unpublished.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and overview of Professor Sher's work on epigenetics and aging at Fudan University.
• 02:00Discussion of the discovery of LSD2 as a key driver in epigenetic regulation and its link to cancer and diabetes.
• 04:00Description of the new healthy longevity center at Fudan University, combining basic science, translational research, and clinical care.
• 06:00Overview of the Chinese Community Aging Cohort, a large longitudinal study with over 550,000 participants.
• 08:00Introduction of a novel nanoliter-scale metabolomics platform and its application to the cohort.
• 10:00Results showing that metabolic fingerprints can distinguish metabolic syndrome and predict mortality.
• 12:00Discussion of taurine's positive effects on metabolic health (unpublished data) and the development of a metabolic aging clock.
• 14:00Integration of lifestyle and continuous glucose monitoring data into risk scores for better clinical management.
• 16:00Conclusion and acknowledgments.